# NeuroVision Imaging

develops retinal amyloid-imaging technology targeting amyloid-beta deposits detectable in retinal tissue, part of the expanding multi-site research literature validating retinal biomarkers against confirmed Alzheimer's diagnostic measures.

Source: https://en.bioecon.ru/companies/neurovision-imaging/
Updated: 2026-07-20

- Country: United States

## Technologies

- [Retinal biomarkers for neurodegenerative disease](https://en.bioecon.ru/technology/retinal-biomarkers-neurodegenerative-disease/)